Ertapenem Injection, Powder, Lyophilized, For Solution
Product Images NDC 42023-221

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ertapenem (NDC 42023-221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ertapenem 01)

Chemical structure of ertapenem sodium, the active ingredient in ERTAPENEM injection, powder, lyophilized, for solution. The diagram depicts the molecular framework including rings, functional groups, and sodium ion associated with the compound.*

FDA Label Image

Principal Display Panel (1 g Vial Tray Label)

Label for Ertapenem Sodium Injection, Powder, Lyophilized, 1 g for IV/IM use. The label displays the product name, dosage form, strength (1 g), and routes of administration (intravenous or intramuscular). It includes instructions for vial use and manufacturer information showing Par Pharmaceutical, NY, and Fareva Mirabel, France. The label also lists inactive ingredients and storage instructions, with the Premier ProRx logo and relevant regulatory details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.